136 related articles for article (PubMed ID: 16258269)
1. Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer.
Bhojani MS; Chen G; Ross BD; Beer DG; Rehemtulla A
Cell Cycle; 2005 Nov; 4(11):1478-81. PubMed ID: 16258269
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772
[TBL] [Abstract][Full Text] [Related]
3. SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer.
Luo J; Chen B; Gao CX; Xie HK; Han CN; Zhou CC
Biochem Biophys Res Commun; 2018 Sep; 504(1):289-294. PubMed ID: 30190126
[TBL] [Abstract][Full Text] [Related]
4. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.
Marín-Rubio JL; Pérez-Gómez E; Fernández-Piqueras J; Villa-Morales M
Carcinogenesis; 2019 Oct; 40(10):1260-1268. PubMed ID: 30805584
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 2A an interactive protein linking phosphorylated FADD to NF-κB pathway leads to colorectal cancer formation.
Marikar FM; Jin G; Sheng W; Ma D; Hua Z
Chin Clin Oncol; 2016 Dec; 5(6):76. PubMed ID: 28061540
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation.
Werner MH; Wu C; Walsh CM
Cell Cycle; 2006 Oct; 5(20):2332-8. PubMed ID: 17102623
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.
Bowman BM; Sebolt KA; Hoff BA; Boes JL; Daniels DL; Heist KA; Galbán CJ; Patel RM; Zhang J; Beer DG; Ross BD; Rehemtulla A; Galbán S
Sci Signal; 2015 Jan; 8(361):ra9. PubMed ID: 25628462
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
[TBL] [Abstract][Full Text] [Related]
9. FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer.
Cimino Y; Costes A; Damotte D; Validire P; Mistou S; Cagnard N; Alifano M; Régnard JF; Chiocchia G; Sautès-Fridman C; Tourneur L
Br J Cancer; 2012 Jun; 106(12):1989-96. PubMed ID: 22669160
[TBL] [Abstract][Full Text] [Related]
10. Multiple functions of FADD in apoptosis, NF-κB-related signaling, and heart development in Xenopus embryos.
Sakamaki K; Takagi C; Kitayama A; Kurata T; Yamamoto TS; Chiba K; Kominami K; Jung SK; Okawa K; Nozaki M; Kubota HY; Ueno N
Genes Cells; 2012 Nov; 17(11):875-96. PubMed ID: 23025414
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of FADD and Bcl-XS proteins as novel prognostic biomarkers for surgically resected non-small cell lung cancer.
Chen L; Xie G; Feng J; Wen Q; Zang H; Lu J; Zhan Y; Fan S
Cancer Biomark; 2021; 30(2):145-154. PubMed ID: 33104018
[TBL] [Abstract][Full Text] [Related]
12. The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation.
Imtiyaz HZ; Zhou X; Zhang H; Chen D; Hu T; Zhang J
J Biol Chem; 2009 Apr; 284(15):9917-26. PubMed ID: 19203997
[TBL] [Abstract][Full Text] [Related]
13. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
14. Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD).
Vilmont V; Filhol O; Hesse AM; Couté Y; Hue C; Rémy-Tourneur L; Mistou S; Cochet C; Chiocchia G
Biochim Biophys Acta; 2015 Nov; 1853(11 Pt A):2885-96. PubMed ID: 26253696
[TBL] [Abstract][Full Text] [Related]
15. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P
Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646
[TBL] [Abstract][Full Text] [Related]
16. A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB.
Schinske KA; Nyati S; Khan AP; Williams TM; Johnson TD; Ross BD; Tomás RP; Rehemtulla A
Mol Cancer Ther; 2011 Oct; 10(10):1807-17. PubMed ID: 21859840
[TBL] [Abstract][Full Text] [Related]
17. Subcellular compartmentalization of FADD as a new level of regulation in death receptor signaling.
Föger N; Bulfone-Paus S; Chan AC; Lee KH
FEBS J; 2009 Aug; 276(15):4256-65. PubMed ID: 19583773
[TBL] [Abstract][Full Text] [Related]
18. Fas-associated death-domain protein inhibits TNF-alpha mediated NF-kappaB activation in cardiomyocytes.
Chao W; Shen Y; Li L; Zhao H; Meiler SE; Cook SA; Rosenzweig A
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2073-80. PubMed ID: 15980038
[TBL] [Abstract][Full Text] [Related]
19. Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
Marín-Rubio JL; de Arriba MC; Cobos-Fernández MA; González-Sánchez L; Ors I; Sastre I; Fernández-Piqueras J; Villa-Morales M
Oncotarget; 2016 Sep; 7(38):61485-61499. PubMed ID: 27556297
[TBL] [Abstract][Full Text] [Related]
20. PKC-θ is a negative regulator of TRAIL-induced and FADD-mediated apoptotic spectrin aggregation.
Michalczyk I; Toporkiewicz M; Dubielecka PM; Chorzalska A; Sikorski AF
Folia Histochem Cytobiol; 2016; 54(1):1-13. PubMed ID: 27094638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
